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Hedyotis diffusa (H. diffusa) Willd. is known to induce apoptosis in cancer cells. However, the molecular 
mechanism of its anti-cancer activity has not been fully elucidated. In this study, we found that the 
ethanol extract of H. diffusa Willd. (EEHDW) reduced cell viability and induced apoptosis in a dose- and 
time-dependent manner in human leukemic THP-1 cells. The induction of apoptosis was also 
accompanied by the down regulation of PI3K/Akt and the inhibitor of apoptosis protein (IAP) family 
proteins. Moreover, we observed that EEHDW treatment resulted in activation of caspase-3, which may 
partly explain the anti-cancer activity of EEHDW. 
 





Medicinal plants are widely used in the treatment of 
various cancers in many Asian countries and are 
recognized as an attractive alternative to surgical therapy 
and radiotherapy (Xie et al., 2009). The herb of Hedyotis 
diffusa Willd. (synonym Oldenlandia diffusa Willd., family 
Rubiaceae), an annual herb distributed in northeastern 
Asia, has been widely used to treat cancer, appendicitis, 
hepatitis, furunculosis, enteritis and bleeding in China 
(Zhang et al., 2010; Xu et al., 2010). Recently, this herb 
has gained increasingly attention to its usage as an 
antitumor herb, such as therapy in liver, lung, colon, brain, 
pancreas and other cancers (Fang et al., 2004). Previous 
studies have shown that the herb has the ability to inhibit 
the proliferation of tumor cells and that the primary extract 
of the herb could induce apoptosis in human breast 
cancer cell line SPC-A (Zhang et al., 2007). However, the 
exact mechanism and signaling pathway involved in 
EEHDW -induced apoptosis have not been fully elucidate.  
The regulation of apoptosis in both normal and 
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cancer research. 20 years ago, several cell lines derived 
from patients with leukemia and blocked at various stages 
of differentiation were intensively used to study 
proliferation, apoptosis and differentiation processes 
(Champelovier et al., 2008). The human monocytic cell 
line THP-1 cell was first derived from the peripheral blood 
of a one year old male with acute monocytic leukaemia 
(Tsuchiya et al., 1980). 
The cellular decision to undergo either cell death or cell 
survival is a very complex process, which depends on the 
integration of multiple survival and death signals (Galluzzi 
et al., 2009). Phosphatidylinositol 3-kinases (PI3K) are a 
family of related intracellular signal transducer enzymes 
that have been linked to a diversity of cellular functions, 
including cell growth, proliferation, differentiation, motility, 
survival and intracellular trafficking (Guan et al., 2009; 
Cardoso et al., 2008). The anti-apoptotic effects of PI3K 
are mediated by its downstream target Akt, which can 
regulate the expression of several apoptosis-related 
genes, such as Bcl-2/Bax (Zheng et al., 2008). The 
activated Akt phosphorylates target molecules including 
mammalian target of rapamycin (mTOR), which modu- 
lates cell proliferation in part by the regulation of initiation 
of translation (Bjornsti et al., 2004; Hay and  Sonenberg, 




2004). In addition to Akt, inhibitor of apoptosis protein 
(IAP) families of proteins also plays a critical role. The 
inhibitor of apoptosis (IAP) family of proteins is the potent 
natural factors that function by directly inhibiting the 
activity of caspase, the principal effectors of apoptosis 
(Turner et al., 2007).  
In this study, we evaluated the antitumor potential of 
EEHDW in leukemia-derived cell lines, THP-1 cells. With 
the aim to clarify the mechanisms underlying H. diffusa 
Willd. cell growth inhibition activity, we analyzed the effect 
of the drug on cell death and apoptosis. The contribution 
of caspase, PI3K/AKT pathway and XIAP families in the 








Monoclonal anti-β-actin antibodies were purchased from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-Phospho-specific 
Akt and Akt; anti-phospho-specific mTOR and mTOR; Anti-XIAP; 
anti-cIAP1; Anti-cIAP2; anti-smac; anti-survivn were obtained from 
New England Biolabs, Bevely, MA; stocks of the selective PI3K/Akt 
inhibitor LY294002; stocks of the selective XIAP inhibitor Embelin 
were obtained from Calbio-chem-Behring, Za Jolla, CA, USA. 
RPMI-1640 and fatal bovine serum (FBS) were purchased from 
Gibco BIL Company (Gibco, NY, USA). An annexin V apoptosis 
detection kit was purchased from RD Systems (Abingdon, U.K.). 
Cell isolation and tissue culture reagents were obtained from 
Invitrogen life Technologies (Lidingo, Sweden). All other reagents 
were obtained from Sigma-Aldrich (St. Lowis, MO, USA). 
 
 
THP-1 cells culture 
 
THP-1 cells obtained from Sun Yat-sen University were used in all 
the experiments and they were grown in RPMI 1640 medium 
supplemented with 10% fetal calf serum, 2 mM L-glutanine, 100 
U/ml
 
penicillin and 100 g/ml
 
streptomycin (RPMI medium) and 
incubated at 37°C in a humidified air containing 5% CO2. The 
exponentially growing THP-1 cells were seeded into 24-well 
flat-bottomed plates at a density of 5×10
5
/ml. The cells were 
collected at different treated-time points. Before induction with 
EEHDW, the cells were washed once with PBS to remove dead 
cells, and incubated in tissue-culture plates for 30 min at 37°C. 
THP-1 cells in multiwell tissue-culture plates were incubated with 
EEHDW at different concentrations (0, 1, 2 and 4 mg/ml) for 2 days 
or at a concentration of 2 mg/ml for 0, 1, 2, 3 and 4 days, 
respectively. In some experiments, 50 µM LY294002 (PI3K inhibitor) 
or 20 µM Embelin (XIAP inhibitor) were used at 30 min before 





To assess the overall viability of THP-1 cells following EEHDW 
treatment, the cells were treated as described earlier. At particular 
time points, the THP-1 cells were washed two times with PBS and 
treated with a 0.4% solution of trypan blue and visualized as clear 
cells under the microscope. THP-1 cells that were no longer viable, 
which had damaged membranes allowed entry of the dye; were 
stained blue. Assays were performed in triplicate and repeated at 









Flow cytometry analysis   
 
THP-1 apoptosis was quantified by flow cytometry using FITC- 
conjugated annexin V and propidium Iodide (PI). Specific binding of 
annexin V was achieved by incubating 10
6
 cells in 60 µl of the 
binding buffer saturated with annexin V for 15 min at 4°C in the dark. 
To discriminate between early apoptosis and necrosis, the cells 
were simultaneously stained with annexin V and PI before analysis. 
The binding of annexin V-FITC and PI to the cells was measured by 
flow cytometry (FACS Calibur, BD Biosciences) using CellQuest 
software. At least 10 000 cells were counted in each sample. 
Experiments were performed and interpreted as follows: cells that 
were Annexin V (-)/ PI (-) (lower left quadrant) were considered as 
living cells, the Annexin V (+)/ PI (-) cells (lower right quadrant) as 
apoptotic cells, Annexin V (+)/ PI (+) (upper right quadrant) as 
necrotic or advanced apoptotic cells and Annexin V (-) / PI (+) 
(upper left quadrant) may be bare nuclei, cells in late necrosis or 
cellular debris.  
 
 
Western blot analysis 
 
After treatment, briefly, cells were washed once with ice-cold 
phosphate buffered saline containing 1 mM Na2VO4 and extracted 
with lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 
5% Glycerol, 1% Triton X-100, 25 mM NaF, 2 mM Na2VO4, 10 µg/ml 
of each aprotinin, leupeptin and pepstatin). The preparation of 
cytoplasmic was conducted using the NE-PER cytoplasmic 
extraction reagents (Pierce). The cell lysates were frozen and 
thawed three times and were further centrifuged at 14 000 × g for 10 
min at 4°C to pellet insoluble material. The supernatant of cell 
extracts was analyzed for protein concentration by using Lowry’s 
technique (Bio-Rad, Hercules, CA, USA). Equal amounts of protein 
(50 µg) from each sample were separated on 10% sodium dodecyl 
sulfate-polyacrylamide gels and transferred to PVDF membranes 
(MSI, Westborough, MA, USA). Membranes were blocked in 5% 
nonfat dry milk in Tris-buffered saline containing 0.05% Tween-20 
(TBST) and then incubated with rabbit polyclonal for Phospho- 
specific Akt (Ser 473) and Akt (1:2000 dilution); Phospho-specific 
mTOR (289KD) and mTOR (1:2000 dilution); XIAP(57KD, 1:2000 
dilution); cIAP1 (70 KD, 1:2000 dilution); cIAP2 (68 KD, 1:2000 
dilution); Smac (22 KD, 1:2000 dilution) and Survivin (16 KD, 1:2000 
dilution). β-actin (42 KD, 1:2000) was used to control equal protein 
loading. The immunoblots were then washed three times with TBS-T 
buffer, incubated with a horseradish peroxidaseconjugated 
secondary antibody (goat anti-rabbit IgM, Santa Cruz, CA, USA) and 
developed using chemiluminescent substrate (Pierce, Rockford, IL, 
USA). To quantify and compare levels of proteins, the density of 
each band was measured by densitometry. 
 
 
Measurement of caspase-3 activity 
 
THP-1 cells were harvested and centrifuged at 1500 rpm for 10 min. 
Cells were washed two times with PBS (pH 7.4) and then 
resuspended with 50 µl lysis buffer at 4°C and incubated on ice for 
10 min. All subsequent steps were performed on ice. After 
centrifugation, cell extracts were transferred to fresh tubes and 
protein concentrations were measured. Each 50 µl cell extract 
containing 100 µg of protein were combined with equal volumes of 2 
× reaction buffer in a microplate followed by the addition of 5 µl of 
peptide substrates of caspase-3. After overnight incubation in the 
dark at 37°C, samples were read in a microplate reader at 405 nm. 





treated/control samples. In some experiments, caspase-3 inhibitor 
(Z-DEVD-FMK) was added into fresh medium of THP-1 cells at 1 h 
before EEHDW was added. 
 
 
Statistical analysis  
 
Each experiment was carried out in duplicate or triplicate and three 
or four independent experiments were performed. Results were 
expressed as means ± standard deviation (SD) and analyzed with 
SPSS 11.5 software. Results were compared using analysis of 
variance (ANOVA). When ANOVA showed a statistically significant 
difference, a group-by-group comparison was performed using a 
t-test with Tukey’s correction for multiple comparison. Statistical 





EEHDW inhibition of cell viability in human THP-1 
cells 
 
We performed a trypan blue exclusion assay. Trypan blue 
staining showed that 98.23 ± 1.74% of the cells incubated 
with medium retained an integrated cell membrane (that is, 
resisted trypan blue staining) (means ± standard errors of 
the means: n= 5). The percentage of necrosis cells rose 
with the increasing of time and the concentrations of 
EEHDW (Figure 1).  
 
 
EEHDW induction of apoptosis in human THP-1 cells 
 
Flow cytometry using FITC-conjugated annexin V 
revealed that THP-1 cells exposed to EEHDW underwent 
rapid apoptosis. This effect was positively correlated with 
exposure time and the concentrations of EEHDW (Figure 
2) and excessive apoptosis was associated with loss of 
membrane integrity in an increased portion of THP-1, 
which indicates necrosis or late apoptosis.  
 
 
Involvement of PI3K in the apoptosis of THP-1 cells 
 
It was found that EEHDW treatment significantly decrea- 
sed P-Akt and P-mTOR production in a time-dependent 
manner (Figure 3). These experiments support the 
conclusion that EEHDW-induced apoptosis is mediated 
by P-Akt down regulation. LY294002, a potent inhibitor of 
Akt, reduced the levels of P-Akt in a dose-dependent 
manner without affecting basal Akt (data not shown).  
 
 
EEHDW induction of THP-1 apoptotic cell death via 
modulation of XIAP family proteins 
 
Expressions of antiapoptotic protein cIAP1/2, XIAP and 
Survivin were decreased in a time-dependent manner 
(Figure 4). However, the expression of Smac was 
increased in a time-dependent manner (Figure 4). These  




results suggest that the changes in expression of cIAP1/2, 
Survivin, Smac and XIAP may contribute to EEHDW- 
induced apoptogenesis in THP-1 cells. 
 
 
Effects of inhibitors of Akt or XIAP on 
EEHDW-induced THP-1 apoptosis 
 
To identify the relevance of Akt and XIAP signaling 
pathways in controlling the apoptotic cell death by 
EEHDW, inhibition assays were performed with LY294002 
(a specific inhibitor of PI3K) or Embelin (a specific inhibitor 
of XIAP). The percentage of apoptosis was determined by 
flow cytometry. THP-1cells were pretreated with 50 µM 
LY294002 or 20 µM Embelin for 30 min and then cultured 
with EEHDW for 2 days. The results showed that 
LY294002 or Embelin significantly reduced the apoptosis 
rate (Figure 5). 
 
 
Expression of caspase-3 activity 
 
The expression of caspase-3 activity in THP-1 cells 
incubated in the presence of EEHDW is presented in 
Figure 6. Treatment of THP-1 cells with EEHDW for 
different days at a concentration of 2 mg/ml or for 2 days 
at the concentrations of 0, 1, 2 and 4 mg/ml, respectively 
showed marked increase of caspase-3 activation. Activity 
of caspase-3 in THP-1 cells with EEHDW treatment 
showed dose- and time-dependent up-regulation. 
Inhibition of PI3K pathway with LY294002 or XIAP with 
Embelin potentiated the EEHDW-induced caspase-3 
activity. To characterize the pathway of apoptosis execu- 
tion, experiments were carried out using the caspase-3 
inhibitor Z-DEVD-FMK. Apoptosis was greatly reduced by 
Z-DEVD-FMK (Data not shown), whereas, caspase 
inhibitors had no effect on PI3K, XIAP and Smac 
activation in THP-1cells (data not shown). Together, our 
data demonstrated that caspase-3 mediates EEHDW- 





Previous studies demonstrated that EEHDW induces 
apoptosis in human breast cancer cells (Liu et al., 2010). 
In this study, we investigated the in vitro effects of 
EEHDW on cell growth and death in THP-1 cells, a 
human acute monocytic leukemia cell line and examined 
the mechanisms underlying its actions. To the best of our 
knowledge, this study for the first time demonstrated that 
EEHDW induced THP-1 cell apoptosis in a time- and 
dose-dependent manner.  
Apoptosis signaling is regulated by various pro- and 
anti-apoptotic proteins (Ahn et al., 2010). Akt promotes 
cell survival by inhibiting apoptosis and its phos- 
phorylation has been considered a critical factor in the 
aggressiveness of cancer (Lee et al.,  2008).  Although  









Figure 1. Effect of EEHDW  on cell cytotoxicity of THP-1 cells. THP-1 cells were 
incubated with different concentrations of EEHDW for 2 days (A) or 2 mg/ml EEHDW 
for different time (B). Viability of THP-1 cells was determined by trypan blue assay. 
Note that the number of dead cells was increased with EEHDW concentration and 
infection time used. Data represent means ±SD of three determinations (*P < 0.05) 




the precise anti-apoptotic effects of Akt are still unclear, 
Akt directly phosphorylates and inactives procaspase-9 
and blocks caspase-9-mediated apoptosis. Therefore, we 
investigated whether EEHDW induces down regulation of 
PI3K/Akt and whether pretreatment with LY294002 could 
enhance EEHDW-induced apoptosis in THP-1 cells. We 
reported EEHDW induced inactivation of Akt by 
decreasing the level of phosphorylated Akt in a 
concentration-dependent manner, contributing to the 
promotion of apoptosis. In this study, we also found that 
the pharmacological inhibitor of PI3K, LY294002, dramati- 
cally exerted caspase-3 activity under EEHDW treatment 
condition.  
Another family of apoptosis-regulatory proteins, inhi- 
bitors of apoptosis proteins (IAPs), is recently con- 
sidered a valuable target to modulate apoptotic cell death 
in many cancer cells (Ahn et al., 2010). Members of the 
mammalian IAP family include: XIAP, cIAP-1, cIAP-2 and 
others, which directly inhibit caspase-3, caspase -7 and 
caspase-9 (Roy et al., 1997). The main antagonist of 
XIAP is the second mitochondria derived activator of 
caspases  (Smac).  Dimeric  Smac  sterically  and/or  









Figure 2. EEHDW-induced apoptosis in THP-1 cells. THP-1 cells were cultured without or with EEHDW. THP-1 cells were 
harvested for 2 days with different concentration of EEHDW (A) or 2 mg/ml EEHDW for different time (B) and incubated with 
FITC-conjugated annexin V (AV) and propidium iodide (PI) double staining. Flow cytometric analysis was performed and the 
data shown are representative of three separate experiments. The lower right quadrants represent early apoptotic cells that 
were stained by annexin V but not by propidium iodide. The upper right quadrants represent late apoptotic cells that were 




     
 
Figure 3. The expression of phosphorylated and total Akt protein and phosphorylated and 
total mTOR protein in THP-1 cells following treatment of 2 mg/ml EEHDW for the time periods 
indicated. Representative data of three independent experiments are shown.  






Figure 4. The expressions of XIAP family proteins. Whole cell 
extracts were prepared and analyzed by Western blotting 
analysis using Abs against XIAP, cIAP1/2, Survivin, Smac and 
β-actin in THP-1 cells following treatment of 2 mg/ml EEHDW 
for the time periods indicated. Representative data of three 






EEHDW (2 mg/ml) 
LY294002 (50 µM) 
Embelin (20 µM) 
 
 
Figure 5. Effect of Akt or XIAP inhibitors on EEHDW-induced THP-1 cell apoptosis. THP-1 cells were treated with 2 
mg/ml EEHDW and incubated for 2 days with the indicated concentrations of Akt and XIAP inhibitors: 50 µM 
LY294002 or 20 µM Embelin for 30 min. Values represent means ± SD of five experiments performed in duplicate. *P 
< 0.05; ** P < 0.001 compared with that of EEHDW  alone. 










EEHDW (2 mg/ml) 
LY294002 (50 µM) 
Embelin (20 µM) 
 
 
Figure 6. Effect of EEHDW, Akt inhibitor or XIAP inhibitors on the activity of caspase-3. (A) 
Dose-dependency of EEHDW-induced caspase-3 activity; *P < 0.01 compared with that of 0 min; 
(B) time-dependency of EEHDW -induced caspase-3 activity. *P < 0.01 compared with that of 0 
min; (C) THP-1 cells were treated with 2 mg/ml EEHDW and incubated for 2 days, with the 
indicated concentrations of LY294002 or Embelin. Values represent means ± SD of five 
experiments performed in duplicate. *P < 0.05, **P <0.001 compared with that of control. 




competitively occludes the caspase 3, 7 and 9 binding 
sites of XIAP and thereby, can pave the way for efficient 
cell death execution (Wu et al., 2000; Hao et al., 2004). 
Smac also binds to other IAPs, such as livin/ML-IAP, 
Bruce/Apollon, cIAPs 1 and 2 (Bartke et al., 2004; Vucic 
et al., 2002), which interfere with caspase-mediated cell 
death and/or have additional roles in pro-survival and 
proliferation signaling. Nevertheless, it is not currently 
known whether EEHDW-induced apoptosis is related to 
down regulation of the IAP family proteins. In this study, 
there were a tendency of alterations with a decreased 
expression level of cIAP1/2, Survivin and XIAP and also 
with an increased expression level of Smac and activation 
of caspase-3.  
Caspase family, aspartate-specific cysteine proteases, 
plays a central role in regulation of apoptosis (Salvesen 
and Stennicke 1998; Filip et al., 2011; Souza et al., 2010; 
Wei et al., 2010). Caspase-3 in particular, when activated, 
has many cellular targets that when served and/or 
activated, produce the morphologic features of apoptosis 
(Cohen, 1997). Recent studies revealed that the 
modulation of caspases is a complex process and 
involves a number of regulatory proteins, including PI3K 
and IAP family proteins (Roccaro et al., 2010; Chauhan, 
2007). Study of caspases, which are also important 
regulators of apoptosis, revealed that exposure of THP-1 
cells to EEHDW increased caspase-3 activity. To more 
directly link PI3K/Akt and XIAP signaling
 
pathway with 
caspase-3 activation, we examined EEHDW-mediated
 
caspase-3 activation in cells treated with PI3K/Akt or XIAP 
inhibitors LY294002 or Embelin. Inhibition of PI3K/Akt or 
XIAP significantly
 
increased caspase-3 activity. In our 
studies, pretreatment with caspase-3 specific inhibitor 
significantly blocked caspase-3 activity. These results 
suggest that in EEHDW-induced THP-1 cells, LY294002 
or Embelin induced apoptosis, which are dependent on 
the activation of caspase-3. 
In conclusion, the data presented in this study support 
the hypothesis that EEHDW are potential and selective 
anti-cancer agents by modulating apoptosis and 
proliferation in leukemia cells. Further studies should test 
the usefulness (efficacy and toxicity) of these compounds 
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